X

Indraprastha Medical Corporation Ltd. Stock Analysis

Small Cap
Evaluated by 740 users | BSE: 532150 | NSE: INDRAMEDCO |
Hospital & Healthcare Services
Indraprastha Medical Corporation (Indraprastha) was incorporated as public limited company on  March 16,1988 with the ROC and obtained the certificate of commencement of business on April 7,1988.It is a Delhi-based healthcare company which operates through Indraprastha Apollo...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 15.78%13.8%14.77%17.09%15.43%11.63%11.21%9.49%12.15%18.05%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 435522607678714755766753788831
Y-o-Y Gr. Rt.-19.8%16.3%11.7%5.4%5.7%1.4%-1.7%4.7%5.4%
Adjusted EPS (Rs.) 3.022.953.143.883.552.742.912.413.214.84
Y-o-Y Gr. Rt.--2.3%6.4%23.6%-8.5%-22.8%6.2%-17.2%33.2%50.8%
Book Value per Share (Rs.) 16.2917.3718.6520.4121.2524.4125.1825.3426.6229.21
Adjusted Net Profit 27.72728.735.632.525.126.622.129.444.3
Net Op. Cash Flow (Rs. Cr.) 33.455.566.958.164.362.327.647.775.286.5
Debt to Cash Flow from Ops 2.241.211.11.080.780.842.441.370.280.05
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Indraprastha Medical Corporation Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 7.4%3.1%2.8%5.4%
Adjusted EPS 5.4%6.4%18.5%50.8%
Book Value per Share 6.76.65.19.7
Share Price 4.8% -6% -0.5% 25.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 19.4217.5117.4119.8617.031211.729.5312.3517.32
Operating Profit Margin (%) 9.9612.812.9513.4311.8810.6410.369.8510.4310.52
Net Profit Margin (%) 6.355.184.745.254.553.323.482.933.735.34
Debt to Equity 0.50.420.430.340.260.230.290.280.090.01
Working Capital Days 76767776757273695953
Cash Conversion Cycle -1-310-4-6-51-3-13
Entity Percentage Holding
Promoters 51.00%
Institutions 0.02%
Non-Institutions 48.98%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Indraprastha Medical Corporation Ltd.'s performance infers:

Indraprastha Medical Corporation Ltd. earnings have grown by 6.4%, whereas share price has depreciated -6% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Indraprastha Medical Corporation Ltd. share prices over the last 10 years. Here is what we found out:

Indraprastha Medical Corporation Ltd. share price has depreciated 2.5% annually over the past ten years.

Indraprastha Medical Corporation (Indraprastha) was incorporated as public limited company on  March 16,1988 with the ROC and obtained the certificate of commencement of business on April 7,1988.It is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned on December 1995 in collaboration with New Delhi administration. The hospital, spread across an area of 675,000 sq ft, is the

Indraprastha Medical Corporation (Indraprastha) was incorporated as public limited company on  March 16,1988 with the ROC and obtained the certificate of commencement of business on April 7,1988.It is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned on December 1995 in collaboration with New Delhi administration. The hospital, spread across an area of 675,000 sq ft, is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centres such as Apollo cardiac center, Apollo cancer center and Apollo surgical science center, among others. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. It is running a multi super-specialty hospital.

Business area of the company :

It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the company’s diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services.

As of March 31, 2009, Indraprastha Apollo Hospitals performed around 2000 cardiac surgeries, 400 joint replacements, 1000 onco surgeries, 90 liver transplants and 135 renal transplants. The company's hospitals are located in Chennai, Hyderabad, Kolkata, Ahmedabad, Bangalore, Bilaspur and Madurai.

Milestones:

  • 1988- The company was incorporated as public limited company on 16th March with the ROC and obtained the certificate of commencement of business on 7th of April. The hospital has 4 cardio-thoracic surgery operation theatres (OTs), 2 neurosurgery OTs, 5 major OTs, 4 minor OTs, 2 emergency OTs and 1 maternity OT.  These OTs are being used for the various specialties/services that are available in the hospital. 
  • 1990 -The company entered into an agreement with Indian Hospital Corporation on 17th July. IHCL is providing technical consultancy and project consultancy for setting up, commissioning and functioning of the hospital. The Company has also installed 2 DG sets of 750 KVA capacity each as standby arrangements. Three steam boilers with a capacity of 2000 kg/hr each with requisite storage and distribution systems have been installed to meet the requirement of steam. 
  • 1992 -The company entered into an agreement with MCS for redressal of investor grievances for a period of six months from the last date of dispatch of letter of allotment advice/share certificates/refund orders. 
  • 1996 - The Cardiology and Cardiothoracic Surgery have state-of-the-art facilities for cardiac care and treatment.  3 Catheterization laboratories with Digital imaging & electrophysiology facilities have been set-up. The Neuro Sciences department is one of the few centres in Asia providing advanced neuro surgery facilities. Since August, 300 beds have been commissioned with an average occupancy of 200 beds. The Company is setting up Indraprastha Apollo Hospitals a 695 bed multi-disciplinary super specialty tertiary care hospital with state of the art facilities at a site on Delhi-Mathura Road, near Sarita Vihar, New Delhi. The Company proposes to set-up satellite centres in strategic locations in and around Delhi which will have 8-10 consultancy rooms and basic diagnostic facilities. An Incinerator with a capacity of 125 kgs per hour has been installed for disposal of combustible waste, infectious waste, human tissue, bandage, dressing linen etc. IMCL has installed compressors for compressed air and medical gases. The company has entered into an equipment lease agreement with IHCL for leasing of specified medical equipment.
  • 1997- Indraprastha Medical Corporation entered the capital market with a public issue of 2,29,18,900 equity shares of Rs.10 each for cash at par aggregating to Rs.22,91,83,000. Indraprastha Medical Corporation is a multi-speciality 600-bed corporate hospital being set up in New Delhi. Besides the hospital complex the corporate hospital also has plans to set up five satellite centres. The first joint sector venture in healthcare in the country was set up in collaboration with NCT (National Capital Territory) of Delhi, bringing together the strategic focus and operational advantages of the private sector. 
  • 1998 - Recently, a combined team of cardiologists and neurologists successfully developed a new technique of safely embolizing septal artery without affecting vital circulation of the rest of the heart muscle.  The hardware was a combination of material used in coronary angioplasty and cerebral AVM repairs.  This procedure has been performed for the first time in the world. A new technique thrombolysis devised by the neuroradiology unit to treat early stroke victims involves injection of a special medicine directly into the clot within an artery in the brain to dissolve it. Palliative Medicine, for the first time in the country, being offered as a dedicated speciality service by the hospital, is a concept of medical care that provides for people who are terminally ill. The Assisted Reproductive Unit comprising a team of highly skilled and experienced specialists trained in the UK and USA has been commissioned. Eight national and international conferences held with renowned faculty drawn from across ten countries, most important of them being OPTIMA 98 - a 3-day international conference conducted by the Department of Neurosciences, being the first of its kind in the country. A six-month certificate course on Operation Theatre Technology and Tertiary Nursing Care for qualified registered nurses graduated from various institutions commences 1 July, comprising two semesters each of clinical and theoretical practice. The hospital is one of the multicenteric multinational drug trial centres for drug control studies for hypertension. The hospital is now on the internet with the most comprehensive website with, inter alia, an animated walkthru of the hospital, facility for online appointments and updates on all available services. 
  • 1999- The group also has an ambitious plan of setting up hospitals in Ludhiana, Lucknow, Ahmedabad, Vizag and possibly Calcutta and Mumbai. Abroad, after Dubai and Muscat, the company is looking at East Africa and Sri Lanka and Bangladesh. The Apollo Hospitals group has no immediate plans to include its Delhi-based associate company -- Indraprastha Medical Corporation (IMCL) -- in the on-going consolidation process involving merger of the remanning three group companies into single entity. Besides the Delhi Government, IMCL has been promoted by Dr. Reddy and Shrodders Ventures of the UK who together hold 49 per cent stake in the company.  The public holds a 25 per cent stake in IMCL. The agreement entered into between the promoters in 1998 gives an option to the Delhi Government to divest its 26 per cent stake in IMCL in three tranches once the Indraprastha Apollo Hospital becomes fully operational.  The stake has to be divested at a pre-determined compounded rate or the prevailing market price, whichever is higher. 2005 Delist from The Delhi Stock Exchange Association Limited w.e.f. January 20, 2005.

Future Plans

Indraprastha Medical Corporation plans to set up more than ten satellite clinics in and around Delhi to facilitate easy availability of Apollo-type medical services to a larger cross-section of society. These clinics are to take the shape of mini-hospitals with all basic back-up emergency services mainly aimed at providing post-treatment facilities to Apollo Hospitals patients. Each clinic would cost between Rs 10 to Rs 15 million. It also plans to acquire some of the existing small clinics situated at various locations, upgrade them and start as Apollo clinics.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback